Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Clemens

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
British Journal of Cancer|February 25, 2009
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II studyT André, J M Reyes-Vidal, L Fartoux, et al.
Clinical Science (London, England : 1979)|January 1, 1988
A study of the structure of the gene for lecithin: cholesterol acyltransferase in four unrelated individuals with familial lecithin: cholesterol acyltransferase deficiencyS E Humphries, M E Chaves, F Tata, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancyM Pecherstorfer, Z Herrmann, J J Body, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapyM D Green, H Koelbl, J Baselga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2008
Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische OnkologieS-E Al-Batran, J T Hartmann, R Hofheinz, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 1999
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancyR Rizzoli, D Thiébaud, N Bundred, et al.
British Journal of Cancer|November 22, 2012
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104S Boeck, A Jung, R P Laubender, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
British Journal of Cancer|February 25, 2009
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II studyT André, J M Reyes-Vidal, L Fartoux, et al.
Clinical Science (London, England : 1979)|January 1, 1988
A study of the structure of the gene for lecithin: cholesterol acyltransferase in four unrelated individuals with familial lecithin: cholesterol acyltransferase deficiencyS E Humphries, M E Chaves, F Tata, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancyM Pecherstorfer, Z Herrmann, J J Body, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapyM D Green, H Koelbl, J Baselga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2008
Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische OnkologieS-E Al-Batran, J T Hartmann, R Hofheinz, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 1999
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancyR Rizzoli, D Thiébaud, N Bundred, et al.
British Journal of Cancer|November 22, 2012
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104S Boeck, A Jung, R P Laubender, et al.
Pageof 6